The Heartline Study is a virtual heart health wellness study for people 65+
Can this study reduce the risk of strokes from atrial fibrillation?
UPDATED December 28, 2020
- Summary: Join the Heartline Study, a nationwide, virtual heart health study for people 65+ with an iPhone and Original Medicare or Medicare Advantage.
- Reading time: 2 minutes
The Heartline Study is a heart-health wellness program and study being conducted by Johnson & Johnson in collaboration with Apple. The study will determine if a mobile app combined with the Apple watch (Series 4 or later) can identify heartbeat irregularities such as atrial fibrillation.
In addition, the study includes a heart-health engagement program paired with medication adherence tools for those with afib who are on blood thinners (oral anticoagulants). The study aims to determine if these interventions can help reduce the risk of afib-related strokes.
Thus, there is a role in the study for everyone 65+ in the US, both those with afib and those without it.
Please join the study and invite your family and friends who don’t have afib to join as well. Participants may even earn monetary rewards.
To participate, you must meet these qualifications:
- Age 65 or more
- US resident
- iPhone 6s or later, with iOS 12.2 or later
- Original Medicare or Medicare Advantage (NEW)
Learn more about the study, and get started in one simple step (by downloading the app), here:
Find study details at ClinicalTrials.gov, here:
- A Study to Investigate if Early Atrial Fibrillation (AF) Diagnosis Reduces Risk of Events Like Stroke in the Real-World (NCT04276441)
Check out these news stories and media about the Heartline Study:
- Apple and Johnson & Johnson team up on new study to see if Apple Watch can reduce risk of stroke
- Can an Apple Watch App Reduce Your Risk of a Stroke?
- Johnson & Johnson, Apple’s New Virtual Trial Model Shows Early Enrollment Success
- Video: The Talk
- New Study: Can Everyday Technology Prevent Stroke?
Disclaimer: Our founder, Mellanie True Hills, is a member of the Heartline Study Steering Committee. She is very passionate about the study and what it will tell us and hopes you will consider participating in it.